124 related articles for article (PubMed ID: 35863479)
21. Identification of lung adenocarcinoma biomarkers based on bioinformatic analysis and human samples.
Dong S; Men W; Yang S; Xu S
Oncol Rep; 2020 May; 43(5):1437-1450. PubMed ID: 32323809
[TBL] [Abstract][Full Text] [Related]
22. Study on miRNAs in Pan-Cancer of the Digestive Tract Based on the Illumina HiSeq System Data Sequencing.
Lai CH; Liang XZ; Liang XY; Ma SJ; Li JG; Shi MF; Zhu X; Lan HH; Zeng JH
Biomed Res Int; 2019; 2019():8016120. PubMed ID: 31737678
[TBL] [Abstract][Full Text] [Related]
23. UBE2C affects breast cancer proliferation through the AKT/mTOR signaling pathway.
Lu ZN; Song J; Sun TH; Sun G
Chin Med J (Engl); 2021 Oct; 134(20):2465-2474. PubMed ID: 34620747
[TBL] [Abstract][Full Text] [Related]
24. Lentivirus-mediated RNA Interference Targeting LAPTM4B Inhibits Human Ovarian Cancer Cell Invasion In Vitro.
Meng F; Chen X; Song H; Lou G; Fu S
Chem Biol Drug Des; 2016 Jan; 87(1):121-30. PubMed ID: 26247403
[TBL] [Abstract][Full Text] [Related]
25. Structure analysis and expressions of a novel tetratransmembrane protein, lysosoma-associated protein transmembrane 4 beta associated with hepatocellular carcinoma.
Liu XR; Zhou RL; Zhang QY; Zhang Y; Jin YY; Lin M; Rui JA; Ye DX
World J Gastroenterol; 2004 Jun; 10(11):1555-9. PubMed ID: 15162524
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-132-3p inhibits tumor malignant progression by regulating lysosomal-associated protein transmembrane 4 beta in breast cancer.
Li S; Xu JJ; Zhang QY
Cancer Sci; 2019 Oct; 110(10):3098-3109. PubMed ID: 31389121
[TBL] [Abstract][Full Text] [Related]
27. LAPTM4B is associated with poor prognosis in NSCLC and promotes the NRF2-mediated stress response pathway in lung cancer cells.
Maki Y; Fujimoto J; Lang W; Xu L; Behrens C; Wistuba II; Kadara H
Sci Rep; 2015 Sep; 5():13846. PubMed ID: 26343532
[TBL] [Abstract][Full Text] [Related]
28. Bioinformatics-based analysis of the lncRNA-miRNA-mRNA and TF regulatory networks reveals functional genes in esophageal squamous cell carcinoma.
Ye Z; Fang J; Wang Z; Wang L; Li B; Liu T; Wang Y; Hua J; Wang F; Fu Z
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32662828
[TBL] [Abstract][Full Text] [Related]
29. Identification of potential hub genes related to the progression and prognosis of hepatocellular carcinoma through integrated bioinformatics analysis.
Song X; Du R; Gui H; Zhou M; Zhong W; Mao C; Ma J
Oncol Rep; 2020 Jan; 43(1):133-146. PubMed ID: 31746405
[TBL] [Abstract][Full Text] [Related]
30. Down-Regulation of miR-2053 Inhibits the Development and Progression of Esophageal Carcinoma by Targeting Fyn-Related Kinase (FRK).
Wang B; Zhang L; Li J; Hua P; Zhang Y
Dig Dis Sci; 2020 Oct; 65(10):2853-2862. PubMed ID: 31894485
[TBL] [Abstract][Full Text] [Related]
31. LAPTM4B is a novel diagnostic and prognostic marker for lung adenocarcinoma and associated with mutant EGFR.
Wang L; Meng Y; Zhang QY
BMC Cancer; 2019 Apr; 19(1):293. PubMed ID: 30940109
[TBL] [Abstract][Full Text] [Related]
32. Autophagy-related gene LAPTM4B promotes the progression of renal clear cell carcinoma and is associated with immunity.
Wang H; Wang Q; Wu Y; Lou J; Zhu S; Xu Y
Front Pharmacol; 2023; 14():1118217. PubMed ID: 36937841
[TBL] [Abstract][Full Text] [Related]
33. Identification of Autophagy-Related Genes and Small-Molecule Drugs in Esophageal Carcinoma.
Li Z; Dong K; Guo P; Tan Z; Zhang F; Tian Y; Lv H
Med Sci Monit; 2020 May; 26():e921855. PubMed ID: 32415055
[TBL] [Abstract][Full Text] [Related]
34. KIF4A enhanced cell proliferation and migration via Hippo signaling and predicted a poor prognosis in esophageal squamous cell carcinoma.
Sun X; Chen P; Chen X; Yang W; Chen X; Zhou W; Huang D; Cheng Y
Thorac Cancer; 2021 Feb; 12(4):512-524. PubMed ID: 33350074
[TBL] [Abstract][Full Text] [Related]
35. TPX2 expression is associated with cell proliferation and patient outcome in esophageal squamous cell carcinoma.
Hsu PK; Chen HY; Yeh YC; Yen CC; Wu YC; Hsu CP; Hsu WH; Chou TY
J Gastroenterol; 2014 Aug; 49(8):1231-40. PubMed ID: 23963785
[TBL] [Abstract][Full Text] [Related]
36. Bioinformatics Analysis of Autophagy-related lncRNAs in Esophageal Carcinoma.
Wu D; Ding Y; Fan J
Comb Chem High Throughput Screen; 2022; 25(8):1374-1384. PubMed ID: 34170806
[TBL] [Abstract][Full Text] [Related]
37. Integrative genomics analysis of hub genes and their relationship with prognosis and signaling pathways in esophageal squamous cell carcinoma.
Chen FF; Zhang SR; Peng H; Chen YZ; Cui XB
Mol Med Rep; 2019 Oct; 20(4):3649-3660. PubMed ID: 31485619
[TBL] [Abstract][Full Text] [Related]
38. Identification of candidate aberrantly methylated and differentially expressed genes in Esophageal squamous cell carcinoma.
Han BA; Yang XP; Hosseini DK; Zhang P; Zhang Y; Yu JT; Chen S; Zhang F; Zhou T; Sun HY
Sci Rep; 2020 Jun; 10(1):9735. PubMed ID: 32546690
[TBL] [Abstract][Full Text] [Related]
39. Identification of crucial genes correlated with esophageal cancer by integrated high-throughput data analysis.
Zhou W; Wu J; Liu X; Ni M; Meng Z; Liu S; Jia S; Zhang J; Guo S; Zhang X
Medicine (Baltimore); 2020 May; 99(20):e20340. PubMed ID: 32443386
[TBL] [Abstract][Full Text] [Related]
40. Identification of key candidate genes involved in melanoma metastasis.
Chen J; Wu F; Shi Y; Yang D; Xu M; Lai Y; Liu Y
Mol Med Rep; 2019 Aug; 20(2):903-914. PubMed ID: 31173190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
